SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-22-000026
Filing Date
2022-01-20
Accepted
2022-01-20 09:38:22
Documents
56
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q rgbp123121form10q.htm   iXBRL 10-Q 1357141
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 9507
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 9486
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 4232
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 4103
  Complete submission text file 0001607062-22-000026.txt   4717668

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE rgbp-20211231.xsd EX-101.SCH 49709
7 XBRL CALCULATION FILE rgbp-20211231_cal.xml EX-101.CAL 48899
8 XBRL DEFINITION FILE rgbp-20211231_def.xml EX-101.DEF 150849
9 XBRL LABEL FILE rgbp-20211231_lab.xml EX-101.LAB 268898
10 XBRL PRESENTATION FILE rgbp-20211231_pre.xml EX-101.PRE 221674
50 EXTRACTED XBRL INSTANCE DOCUMENT rgbp123121form10q_htm.xml XML 602988
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-722-5505
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-191725 | Film No.: 22540921
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences